Global Tuberculosis Vaccine Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Tuberculosis Vaccine Drug Market Growth Status and Outlook 2025-2031

The global Tuberculosis Vaccine Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Tuberculosis Vaccine Drug Industry Forecast looks at past sales and reviews total world Tuberculosis Vaccine Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccine Drug sales for 2025 through 2031. With Tuberculosis Vaccine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccine Drug industry. This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Tuberculosis Vaccine Drug market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccine Drug. This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccine Drug market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Immune Vaccine &nbsp;&nbsp;&nbsp; Therapy Vaccine Segmentation by Application: &nbsp;&nbsp;&nbsp; Self-Procurement &nbsp;&nbsp;&nbsp; UNICEF &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Japan BCG Lab &nbsp;&nbsp;&nbsp; Serum Institute of India &nbsp;&nbsp;&nbsp; AJ Vaccines &nbsp;&nbsp;&nbsp; BioFarma &nbsp;&nbsp;&nbsp; GreenSignal Bio Pharma &nbsp;&nbsp;&nbsp; China National Biotec &nbsp;&nbsp;&nbsp; Biomed Lublin &nbsp;&nbsp;&nbsp; Taj Pharmaceuticals &nbsp;&nbsp;&nbsp; Ataulpho de Paiva &nbsp;&nbsp;&nbsp; IVAC &nbsp;&nbsp;&nbsp; Queen Saovabha Mem. Inst &nbsp;&nbsp;&nbsp; Microgen Key Questions Addressed in this Report What is the 10-year outlook for the global Tuberculosis Vaccine Drug market? What factors are driving Tuberculosis Vaccine Drug market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Tuberculosis Vaccine Drug market opportunities vary by end market size? How does Tuberculosis Vaccine Drug break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Tuberculosis Vaccine Drug Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Tuberculosis Vaccine Drug by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Tuberculosis Vaccine Drug by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Tuberculosis Vaccine Drug Segment by Type &nbsp;2.2.1 Immune Vaccine &nbsp;2.2.2 Therapy Vaccine &nbsp;2.3 Tuberculosis Vaccine Drug Sales by Type &nbsp;2.3.1 Global Tuberculosis Vaccine Drug Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Tuberculosis Vaccine Drug Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Tuberculosis Vaccine Drug Sale Price by Type (2020-2025) &nbsp;2.4 Tuberculosis Vaccine Drug Segment by Application &nbsp;2.4.1 Self-Procurement &nbsp;2.4.2 UNICEF &nbsp;2.4.3 Other &nbsp;2.5 Tuberculosis Vaccine Drug Sales by Application &nbsp;2.5.1 Global Tuberculosis Vaccine Drug Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Tuberculosis Vaccine Drug Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Tuberculosis Vaccine Drug Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Tuberculosis Vaccine Drug Breakdown Data by Company &nbsp;3.1.1 Global Tuberculosis Vaccine Drug Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Tuberculosis Vaccine Drug Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Tuberculosis Vaccine Drug Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Tuberculosis Vaccine Drug Revenue by Company (2020-2025) &nbsp;3.2.2 Global Tuberculosis Vaccine Drug Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Tuberculosis Vaccine Drug Sale Price by Company &nbsp;3.4 Key Manufacturers Tuberculosis Vaccine Drug Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Tuberculosis Vaccine Drug Product Location Distribution &nbsp;3.4.2 Players Tuberculosis Vaccine Drug Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Tuberculosis Vaccine Drug by Geographic Region &nbsp;4.1 World Historic Tuberculosis Vaccine Drug Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Tuberculosis Vaccine Drug Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Tuberculosis Vaccine Drug Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Tuberculosis Vaccine Drug Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Tuberculosis Vaccine Drug Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Tuberculosis Vaccine Drug Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Tuberculosis Vaccine Drug Sales Growth &nbsp;4.4 APAC Tuberculosis Vaccine Drug Sales Growth &nbsp;4.5 Europe Tuberculosis Vaccine Drug Sales Growth &nbsp;4.6 Middle East & Africa Tuberculosis Vaccine Drug Sales Growth 5 Americas &nbsp;5.1 Americas Tuberculosis Vaccine Drug Sales by Country &nbsp;5.1.1 Americas Tuberculosis Vaccine Drug Sales by Country (2020-2025) &nbsp;5.1.2 Americas Tuberculosis Vaccine Drug Revenue by Country (2020-2025) &nbsp;5.2 Americas Tuberculosis Vaccine Drug Sales by Type (2020-2025) &nbsp;5.3 Americas Tuberculosis Vaccine Drug Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Tuberculosis Vaccine Drug Sales by Region &nbsp;6.1.1 APAC Tuberculosis Vaccine Drug Sales by Region (2020-2025) &nbsp;6.1.2 APAC Tuberculosis Vaccine Drug Revenue by Region (2020-2025) &nbsp;6.2 APAC Tuberculosis Vaccine Drug Sales by Type (2020-2025) &nbsp;6.3 APAC Tuberculosis Vaccine Drug Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Tuberculosis Vaccine Drug by Country &nbsp;7.1.1 Europe Tuberculosis Vaccine Drug Sales by Country (2020-2025) &nbsp;7.1.2 Europe Tuberculosis Vaccine Drug Revenue by Country (2020-2025) &nbsp;7.2 Europe Tuberculosis Vaccine Drug Sales by Type (2020-2025) &nbsp;7.3 Europe Tuberculosis Vaccine Drug Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Tuberculosis Vaccine Drug by Country &nbsp;8.1.1 Middle East & Africa Tuberculosis Vaccine Drug Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Tuberculosis Vaccine Drug Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Tuberculosis Vaccine Drug Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Tuberculosis Vaccine Drug Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Drug &nbsp;10.3 Manufacturing Process Analysis of Tuberculosis Vaccine Drug &nbsp;10.4 Industry Chain Structure of Tuberculosis Vaccine Drug 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Tuberculosis Vaccine Drug Distributors &nbsp;11.3 Tuberculosis Vaccine Drug Customer 12 World Forecast Review for Tuberculosis Vaccine Drug by Geographic Region &nbsp;12.1 Global Tuberculosis Vaccine Drug Market Size Forecast by Region &nbsp;12.1.1 Global Tuberculosis Vaccine Drug Forecast by Region (2026-2031) &nbsp;12.1.2 Global Tuberculosis Vaccine Drug Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Tuberculosis Vaccine Drug Forecast by Type (2026-2031) &nbsp;12.7 Global Tuberculosis Vaccine Drug Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck &nbsp;13.1.1 Merck Company Information &nbsp;13.1.2 Merck Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.1.3 Merck Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck Main Business Overview &nbsp;13.1.5 Merck Latest Developments &nbsp;13.2 Japan BCG Lab &nbsp;13.2.1 Japan BCG Lab Company Information &nbsp;13.2.2 Japan BCG Lab Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Japan BCG Lab Main Business Overview &nbsp;13.2.5 Japan BCG Lab Latest Developments &nbsp;13.3 Serum Institute of India &nbsp;13.3.1 Serum Institute of India Company Information &nbsp;13.3.2 Serum Institute of India Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.3.3 Serum Institute of India Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Serum Institute of India Main Business Overview &nbsp;13.3.5 Serum Institute of India Latest Developments &nbsp;13.4 AJ Vaccines &nbsp;13.4.1 AJ Vaccines Company Information &nbsp;13.4.2 AJ Vaccines Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.4.3 AJ Vaccines Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 AJ Vaccines Main Business Overview &nbsp;13.4.5 AJ Vaccines Latest Developments &nbsp;13.5 BioFarma &nbsp;13.5.1 BioFarma Company Information &nbsp;13.5.2 BioFarma Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.5.3 BioFarma Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 BioFarma Main Business Overview &nbsp;13.5.5 BioFarma Latest Developments &nbsp;13.6 GreenSignal Bio Pharma &nbsp;13.6.1 GreenSignal Bio Pharma Company Information &nbsp;13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 GreenSignal Bio Pharma Main Business Overview &nbsp;13.6.5 GreenSignal Bio Pharma Latest Developments &nbsp;13.7 China National Biotec &nbsp;13.7.1 China National Biotec Company Information &nbsp;13.7.2 China National Biotec Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.7.3 China National Biotec Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 China National Biotec Main Business Overview &nbsp;13.7.5 China National Biotec Latest Developments &nbsp;13.8 Biomed Lublin &nbsp;13.8.1 Biomed Lublin Company Information &nbsp;13.8.2 Biomed Lublin Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.8.3 Biomed Lublin Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Biomed Lublin Main Business Overview &nbsp;13.8.5 Biomed Lublin Latest Developments &nbsp;13.9 Taj Pharmaceuticals &nbsp;13.9.1 Taj Pharmaceuticals Company Information &nbsp;13.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Taj Pharmaceuticals Main Business Overview &nbsp;13.9.5 Taj Pharmaceuticals Latest Developments &nbsp;13.10 Ataulpho de Paiva &nbsp;13.10.1 Ataulpho de Paiva Company Information &nbsp;13.10.2 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Ataulpho de Paiva Main Business Overview &nbsp;13.10.5 Ataulpho de Paiva Latest Developments &nbsp;13.11 IVAC &nbsp;13.11.1 IVAC Company Information &nbsp;13.11.2 IVAC Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.11.3 IVAC Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 IVAC Main Business Overview &nbsp;13.11.5 IVAC Latest Developments &nbsp;13.12 Queen Saovabha Mem. Inst &nbsp;13.12.1 Queen Saovabha Mem. Inst Company Information &nbsp;13.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Queen Saovabha Mem. Inst Main Business Overview &nbsp;13.12.5 Queen Saovabha Mem. Inst Latest Developments &nbsp;13.13 Microgen &nbsp;13.13.1 Microgen Company Information &nbsp;13.13.2 Microgen Tuberculosis Vaccine Drug Product Portfolios and Specifications &nbsp;13.13.3 Microgen Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Microgen Main Business Overview &nbsp;13.13.5 Microgen Latest Developments 14 Research Findings and Conclusion

Report	Global Tuberculosis Vaccine Drug Market Growth 2025-2031
Selected License	Multi ID: LPI36204

Buyer Information

Order Summary